Education
About Us
Working with TipRanks
Follow Us
Physiomics PLC (GB:PYC)
LSE:PYC
PYC Stock Chart & Stats
0.28p
0.05p(6.45%)
At close: 4:00 PM EST
0.28p
0.05p(6.45%)
Day’s Range― - ―
52-Week Range0.25p - 0.80p
Previous CloseN/A
Volume16.21M
Average Volume (3M)2.43M
Market Cap
£1.52M
Enterprise Value1.26M
Total Cash (Recent Filing)£257.00K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding303,208,700
10 Day Avg. Volume1,168,038
30 Day Avg. Volume2,434,740
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.60
Price to Sales (P/S)1.41
P/FCF Ratio-2.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetHaving essentially no debt provides durable financial flexibility over 2-6 months: it lowers mandatory cash outflows, reduces refinancing pressure, and gives management time to focus on improving operations and winning contracts without near-term interest burden or covenant risk.
Strong Recent Revenue ReboundA material revenue rebound indicates improving demand for modelling services and validates the commercial model. Sustained top-line recovery over the medium term supports scale economies and increases the probability management can translate higher sales into incremental gross margin and project pipeline expansion.
Specialized, High-value Service OfferingFocus on quantitative modelling for drug R&D is a structural advantage: high technical barriers, client stickiness and multi-stage engagements tend to create repeat business and pricing power over time, supporting durable revenue visibility and competitive differentiation.
Bears Say
Persistent Cash BurnRepeated negative operating and free cash flow creates a lasting financing overhang: the business cannot self-fund growth, raising the likelihood of external capital needs, dilution or constrained investment in sales and R&D, which can slow scaling and weaken competitiveness.
Ongoing Net Losses And Weak MarginsSustained net losses and negative margins undermine the firm's ability to convert higher revenue into profits. Without margin recovery, profitability remains elusive, pressuring return metrics and limiting resources to invest in client acquisition or higher-margin offerings over the medium term.
Negative ROE And Small Equity CushionA deeply negative ROE and modest equity base indicate persistent value dilution risk. Continued losses against a small equity cushion could force dilutive fundraising or limit strategic flexibility, constraining long-term resilience and increasing shareholder dilution risk if performance does not improve.
Physiomics News
PYC FAQ
What was Physiomics PLC’s price range in the past 12 months?
Physiomics PLC lowest share price was 0.25p and its highest was 0.80p in the past 12 months.
What is Physiomics PLC’s market cap?
Physiomics PLC’s market cap is £1.52M.
When is Physiomics PLC’s upcoming earnings report date?
Physiomics PLC’s upcoming earnings report date is Sep 24, 2026 which is in 213 days.
How were Physiomics PLC’s earnings last quarter?
Physiomics PLC released its earnings results on Feb 16, 2026. The company reported -0.001p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001p.
Is Physiomics PLC overvalued?
According to Wall Street analysts Physiomics PLC’s price is currently Overvalued.
Does Physiomics PLC pay dividends?
Physiomics PLC does not currently pay dividends.
What is Physiomics PLC’s EPS estimate?
Physiomics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Physiomics PLC have?
Physiomics PLC has 303,208,700 shares outstanding.
What happened to Physiomics PLC’s price movement after its last earnings report?
Physiomics PLC reported an EPS of -0.001p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -15.385%.
Which hedge fund is a major shareholder of Physiomics PLC?
Currently, no hedge funds are holding shares in GB:PYC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Physiomics PLC
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.